Related Experiment Video
Updated: Mar 31, 2026

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
Published on: January 24, 2020
The COMTp.Val158Met Polymorphism and Cognitive Performance in Adult Development, Healthy Aging and Mild Cognitive
Christina Degen1, Johannes Zschocke, Pablo Toro
1Section of Geriatric Psychiatry, University of Heidelberg, Heidelberg, Germany.
The catechol-O-methyltransferase (COMT) gene variant impacts midlife attention and cognitive flexibility. Its influence diminishes with healthy aging and mild cognitive impairment development.
Area of Science:
- Neuroscience
- Genetics
- Cognitive Psychology
Background:
- Cognitive function is thought to be increasingly influenced by genetic factors with age.
- The catechol-O-methyltransferase (COMT) p.Val158Met polymorphism's role in cognition across the lifespan is not fully understood.
- Investigating this polymorphism in relation to cognitive capacity in adult development, healthy aging, and mild cognitive impairment (MCI) is crucial.
Purpose of the Study:
- To examine the association between the COMT p.Val158Met polymorphism and cognitive performance.
- To determine if this association differs across adult development, healthy aging, and MCI.
- To compare findings in two distinct birth cohorts (1930-32 and 1950-52).
Main Methods:
- Neuropsychological assessments were performed on 587 participants across three waves (1993-2008).
- COMT genotype was determined using PCR amplification and NlaIII digestion.
- Participants were analyzed based on their birth cohort.
Main Results:
- The COMT p.Val158Met polymorphism significantly affected attention and cognitive flexibility in the younger cohort.
- No significant effects of the COMT p.Val158Met polymorphism were found for attention and cognitive flexibility in the older cohort.
- The impact of the COMT genotype on these cognitive functions was age-dependent.
Conclusions:
- The COMT p.Val158Met genotype is important for attention and cognitive flexibility in midlife.
- Its influence is less pronounced in healthy aging and the development of MCI.
- The study suggests that the effect of COMT on cognition decreases from midlife into older age.
More Related Videos
10:13Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
Published on: February 14, 2014
10:02Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology
Published on: May 28, 2017
Related Concept Videos
Cognitive Development During Adulthood
Pharmacodynamics in Geriatric Patients: Effects of Age
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Alzheimer's Disease: Treatment
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism